Chemokines: understanding their role in T-lymphocyte biology

被引:170
作者
Ward, SG [1 ]
Westwick, J [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
D O I
10.1042/bj3330457
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The chemokines are a complex superfamily of small, secreted proteins that were initially characterized through their chemotactic effects on a variety of leucocytes. The superfamily is divided into families based on structural and genetic considerations and have been termed the CXC, CC, C and CX,C families. Chemokines from these families have a key role in the recruitment and function of T lymphocytes. Moreover, T lymphocytes have also been identified as a source of a number of chemokines. T lymphocytes also express most of the known CXC and CC chemokine receptors to an extent that depends on their state of activation/differentiation and/or the activating stimuli. The expression of two chemokine receptors, namely CXCR4 and CCR5, together with the regulated production of their respective ligands, appears to be extremely important in determining sensitivity of T cells to HIV-I infection. The intracellular events which mediate the effects of chemokines, particularly those elicited by the CC chemokine RANTES, include activation of both G-protein- and protein tyrosine kinase-coupled signalling pathways. The present review describes our current understanding of the structure and expression of chemokines and their receptors, the effects of chemokines on T-cell function(s), the intracellular signalling pathways activated by chemokines and the role of certain chemokines and chemokine receptors in determining sensitivity to HIV-I infection.
引用
收藏
页码:457 / 470
页数:14
相关论文
共 172 条
  • [1] A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells
    Adema, GJ
    Hartgers, F
    Verstraten, R
    deVries, E
    Marland, G
    Menon, S
    Foster, J
    Xu, YM
    Nooyen, P
    McClanahan, T
    Bacon, KB
    Figdor, CG
    [J]. NATURE, 1997, 387 (6634) : 713 - 717
  • [2] HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: Independence from G protein signaling and importance of coreceptor downmodulation
    Alkhatib, G
    Locati, M
    Kennedy, PE
    Murphy, PM
    Berger, EA
    [J]. VIROLOGY, 1997, 234 (02) : 340 - 348
  • [3] HIV coreceptor downregulation as antiviral principle: SDF-1 alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication
    Amara, A
    LeGall, S
    Schwartz, O
    Salamero, J
    Montes, M
    Loetscher, P
    Baggiolini, M
    Virelizier, JL
    ArenzanaSeisdedos, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (01) : 139 - 146
  • [4] Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor
    Aramori, I
    Zhang, J
    Ferguson, SSG
    Bieniasz, PD
    Cullen, BR
    Caron, MG
    [J]. EMBO JOURNAL, 1997, 16 (15) : 4606 - 4616
  • [5] HIV blocked by chemokine antagonist
    ArenzanaSeisdedos, F
    Virelizier, JL
    Rousset, D
    ClarkLewis, I
    Loetscher, P
    Moser, B
    Baggiolini, M
    [J]. NATURE, 1996, 383 (6599) : 400 - 400
  • [6] Multiple extracellular elements of CCR5 and HIV-1 entry: Dissociation from response to chemokines
    Atchison, RE
    Gosling, J
    Monteclaro, FS
    Franci, C
    Digilio, L
    Charo, IF
    Goldsmith, MA
    [J]. SCIENCE, 1996, 274 (5294) : 1924 - 1926
  • [7] Human immunodeficiency virus-1 entry into purified blood dendritic cells through CC and CXC chemokine coreceptors
    Ayehunie, S
    GarciaZepeda, EA
    Hoxie, JA
    Horuk, R
    Kupper, TS
    Luster, AD
    Ruprecht, RM
    [J]. BLOOD, 1997, 90 (04) : 1379 - 1386
  • [8] BACON KB, 1995, J IMMUNOL, V154, P3654
  • [9] Bacon KB, 1998, J IMMUNOL, V160, P1894
  • [10] RANTES induces tyrosine kinase activity of stably complexed p125(FAK) and ZAP-70 in human T cells
    Bacon, KB
    Szabo, MC
    Yssel, H
    Bolen, JB
    Schall, TJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) : 873 - 882